|

Optimization of the Targeted Anticancer Therapies

RECRUITINGN/ASponsored by Centre Hospitalier Universitaire Vaudois
Actively Recruiting
PhaseN/A
SponsorCentre Hospitalier Universitaire Vaudois
Started2015-05
Est. completion2020-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04484064

Summary

The study includes an observational pharmacokinetic study and an interventional medication adherence study. The purpose of this study is 1) to describe the concentration-time profiles of targeted anticancer drugs and to characterize the concentration-effect/toxicity relationships in the target population of patients (observational study) and 2) to characterize patterns of adherence to oral targeted anticancer drugs and identify key-driver modifiable adherence factors in patients participating in an adherence program (interventional study).

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Cancer patients to whom a targeted anticancer therapy is prescribed

Exclusion Criteria:

* Patients incapable of judgment or participants under tutelage

Conditions1

Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.